Cipher Drug Patent Portfolio
Cipher owns 1 orange book drug protected by 5 US patents Given below is the list of Cipher's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9895388 | Methods and compositions useful for controlling cutaneous mites | 25 Nov, 2033 | Active |
| US7030095 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs | 02 Jul, 2021 | Expired |
| US6063771 | Formulations for controlling human lice | 22 Jun, 2019 | Expired |
| US6342482 | Formulations for controlling human lice | 22 Jun, 2019 | Expired |
| US5496931 | Insecticide and miticide A83543 compounds and their method of production by fermentation | 05 Mar, 2013 | Expired |
Latest Legal Activities on Cipher's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cipher.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 11 Aug, 2021 | US9895388 |
|
Expire Patent
Critical
| 14 May, 2018 | US7030095 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Feb, 2018 | US9895388 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Feb, 2018 | US9895388 |
|
Application ready for PDX access by participating foreign offices
Critical
| 20 Feb, 2018 | US9895388 |
|
Email Notification
Critical
| 01 Feb, 2018 | US9895388 |
|
Issue Notification Mailed
Critical
| 31 Jan, 2018 | US9895388 |
| Dispatch to FDC | 12 Jan, 2018 | US9895388 |
|
Application Is Considered Ready for Issue
Critical
| 12 Jan, 2018 | US9895388 |
|
Issue Fee Payment Verified
Critical
| 10 Jan, 2018 | US9895388 |
|
Issue Fee Payment Received
Critical
| 10 Jan, 2018 | US9895388 |
|
Maintenance Fee Reminder Mailed
Critical
| 27 Nov, 2017 | US7030095 |
|
Mail Notice of Allowance
Critical
| 19 Oct, 2017 | US9895388 |
|
Email Notification
Critical
| 19 Oct, 2017 | US9895388 |
|
Electronic Review
Critical
| 19 Oct, 2017 | US9895388 |
Cipher's Family Patents
Cipher Drug List
Given below is the complete list of Cipher's drugs and the patents protecting them.
1. Natroba
Natroba is protected by 5 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9895388 | Methods and compositions useful for controlling cutaneous mites |
25 Nov, 2033
(7 years from now)
| Active |
| US7030095 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
02 Jul, 2021
(4 years ago)
| Expired |
| US6063771 | Formulations for controlling human lice |
22 Jun, 2019
(6 years ago)
| Expired |
| US6342482 | Formulations for controlling human lice |
22 Jun, 2019
(6 years ago)
| Expired |
| US5496931 | Insecticide and miticide A83543 compounds and their method of production by fermentation |
05 Mar, 2013
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Natroba's drug page